This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

James Trussell, PhD

Arch Dermatol. 1995;131(9):1064-1068.

Abstract
Will it work?'' is the question usually asked first and most frequently about any contraceptive method. This question is especially salient for women using teratogenic drugs and their clinicians, particularly dermatologists. As discussed in other articles in this issue of the ARCHIVES, dermatologists prescribe two of the most potent teratogenic drugs, isotretinoin (Accutane, Roche Laboratories, Nutley, NJ) and thalidomide.^1,2 Because this question cannot be answered with certainty for any particular couple, most clinicians and counselors try to help patients understand factors influencing contraceptive efficacy.

Author Affiliations
From the Office of Population Research, Princeton (NJ) University.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?